1921
Volume 91, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Cutaneous leishmaniasis is rarely seen in the United States. Four Cuban immigrants traveled along the same route at different times from Cuba to Ecuador, then northward, including through the Darién Jungle in Panama. These patients had chronic ulcerative non-healing skin lesions and were given a diagnosis of leishmaniasis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0124
2014-08-06
2017-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/2/345.html?itemId=/content/journals/10.4269/ajtmh.14-0124&mimeType=html&fmt=ahah

References

  1. Minodier P, Parola P, , 2007. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 5: 150158.[Crossref]
  2. Christensen HA, de Vasquez AM, Petersen JL, , 1999. Short report epidemiologic studies on cutaneous leishmaniasis in eastern Panama. Am J Trop Med Hyg 60: 5457.
  3. Bethancourt Y, , 2012. Leishmaniasis Causa Dolor en Capira. Panama City, Panama: La Estrella.
  4. Antinori S, Schifanella L, Corbellino M, , 2012. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 31: 109118.[Crossref]
  5. Meyerhoff A, , 1999. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 28: 4248, discussion 49–51.[Crossref]
  6. Wortmann G, Zapor M, Ressner R, Fraser S, Hartzell J, Pierson J, Weintrob A, Magill A, , 2010. Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis. Am J Trop Med Hyg 83: 10281033.[Crossref]
  7. Nonata R, Sampaio R, Marsden PD, , 1997. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome. Trans R Soc Trop Med Hyg 91: 77.[Crossref]
  8. Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E, , 2007. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis . J Am Acad Dermatol 56: 612616.[Crossref]
  9. Sampaio SA, Godoy JT, Paiva L, Dillon NL, da Lacaz CS, , 1960. The treatment of American (mucocutaneous) leishmaniasis with amphotericin B. Arch Dermatol 82: 627635.[Crossref]
  10. Murray HW, , 2012. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 86: 434440.[Crossref]
  11. Solomon M, Pavlotzky F, Barzilai A, Schwartz E, , 2013. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers. J Am Acad Dermatol 68: 284289.[Crossref]
  12. Brown M, Noursadeghi M, Boyle J, Davidson RN, , 2005. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 153: 203205.[Crossref]
  13. Marsden PD, , 1986. Mucosal leishmaniasis (“espundia” Escomel, 1911). Trans R Soc Trop Med Hyg 80: 859876.[Crossref]
  14. Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC, , 2008. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop 105: 19.[Crossref]
  15. Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R, Rodriguez N, , 2000. The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica 16: 925950.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0124
Loading
/content/journals/10.4269/ajtmh.14-0124
Loading

Data & Media loading...

  • Received : 27 Feb 2014
  • Accepted : 22 Apr 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error